Screener
ArriVent BioPharma, Inc. AVBP Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by ArriVent BioPharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-058650
FAQ
- What is ArriVent BioPharma, Inc.'s shares (diluted)?
- ArriVent BioPharma, Inc. (AVBP) reported shares (diluted) of 45.1M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s shares (diluted) changed year-over-year?
- ArriVent BioPharma, Inc.'s shares (diluted) increased by 32.9% year-over-year, from 33.9M to 45.1M.
- What is the long-term trend for ArriVent BioPharma, Inc.'s shares (diluted)?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s shares (diluted) has grown at a 331.0% compound annual growth rate (CAGR), from 8M to 149.3M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about ArriVent BioPharma, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude